Q14-17 Additional Hematologic Labs

* Additional Hematologic Labs
Report the additional hematologic labs prior to the start of the preparative regimen / infusion using results measured within 60 days prior to the start of the preparative regimen. If the assessment was performed multiple times, report the closest value to the start of the preparative regimen

Question 14-17: Select all known hematologic labs (check all that apply).

These questions are intended to capture any hematologic labs within 60 days prior to the start of the preparative regimen.

• Erythroferrone (ERFE): The main erythroid regulator of hepcidin, the homeostatic hormone controlling plasma iron levels and total body iron
• Growth/differentiation factor (GDF15): Member of the transforming growth factor-β superfamily, participates in processes associated with myeloma development and its end-organ complications.
• Nucleated RBC (erythroblast): Premature erythrocyte precursors that reside in the bone marrow of humans of all ages as an element of erythropoiesis.

If none of the labs listed above were completed within 60 days prior to the start of the preparative regimen, select None.

Section Updates:

Question Number	Date of Change	Add/Remove/Modify	Description	Reasoning (If applicable)
.	.	.	.	.

Copyright © 2004-2024 The Medical College of Wisconsin, Inc. and NMDP. All Rights Reserved.
CIBMTR® (Center for International Blood and Marrow Transplant Research) is a research collaboration between the Medical College of Wisconsin and NMDP.